🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06952491
Enrolling by invitation Observational

Research and Engagement on Substance Use: Harnessing Awareness and Personalized Education (RESHAPE) to Improve Well-being and Self-efficacy

NCT06952491 · tracked via the Priya Life Science USA tracker
Sponsor
Evidation Health
Phase
Observational
Started
2025-04
Last updated
2025-05-01

Condition(s) studied

Substance Use Disorder (SUD)

Study summary

The goal of this study is to gather feedback on a potential program that collects and shares real-world information to help create products and services to support people who have substance use disorders.

Eligibility

Sex
ALL
Min age
21 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * U.S. resident * Speaks, read, and understands English * Adults ≥ 21 years of age * Self-reported substance use disorder or at risk for substance use disorder as defined by cannabis use, tobacco use, illegal drug use, or prescription medication use for nonmedical reasons on at least 2-3 times in the past year * Self-reports at least one of the following health-related social needs as assessed by American Academy of Family Physicians Social Needs Screening Tool: * Housing instability * Non-reliable transportation * Food insecurity * Utility needs * Personal safety * Willingness and availability to participate in a recorded online interview (Phase 1A participants) Exclusion Criteria: * Participation in Phase 1A (among Phase 1B participants), to be assessed using participation history

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Evidation Health San Mateo California

Other trials for the same condition

Reentry Assist (R-Assist) Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06952491 on ClinicalTrials.gov ↗ ← All trials in the USA